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Abstract 
Background: Helicobacter pylori is an important risk factor for gastritis, peptic ulcers and gastric cancer. The preva‑
lence in developed countries is lower than 40 % but higher than 80 % in some developing countries. It is 75 % in 
Ghana. The Helicobacter urease test (HUT) is performed at endoscopy and gives an accurate diagnosis. The HUT is not 
routinely done at our facility and presumption of H. pylori is made based on endoscopic findings and H. pylori eradica‑
tion prescribed, as the incidence in the general population is presumed high. Is this endoscopic diagnosis sufficient 
for diagnosing and treating H. pylori? We aimed to assess the feasibility of an endoscopic based H. pylori diagnosis and 
its accuracy using a HUT as the gold standard in consecutive patients.
Methods: Seventy‑six consecutive adult patients with dyspepsia were assessed by upper gastrointestinal endoscopy. 
A clinical diagnosis of H. pylori or not was made. Biopsy samples were collected for HUT. H. pylori was diagnosed if HUT 
was positive. The results were then compared.
Results: Median age of patients was 45.0 years. H. pylori prevalence detected by HUT was 51.3 % (95 % CI 40.0–63.0). 
Sensitivity of endoscopic diagnosis of H. pylori was 71.8 % (95 % CI 55.1–85.0) and specificity was 37.8 % (95 % CI 
22.5–55.2). There was no association between clinical findings (73.7 %) and HUT (26.3 %) (OR = 0.80; [95 % CI 0.24–
2.64], p = 0.682). There was also no association between endoscopic diagnosis (71.8 %) and HUT (28.2 %), (OR = 1.55; 
95 % CI 0.59–4.06, p = 0.373).
Conclusion: Helicobacter pylori infection was not as high as that published in earlier reports. The endoscopic diagno‑
sis alone is not sufficient to make a diagnosis of H. pylori.
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Background
Helicobacter pylori (H. pylori) infection is the most 
common cause of bacterial infection worldwide [1, 2] 
infecting more than 50 % of the world’s population pre-
dominantly in the developing countries [3]. H. pylori is 
an important risk factor for gastritis, peptic ulcers, and 
gastric cancer likely due to the extensive inflammation in 
the stomach [3, 4]. H. pylori has been associated with the 
development of two forms of cancer and has led to the 
World Health Organization (WHO) classifying it as the 
only bacterial Class I carcinogen. Unless treated, coloni-
zation usually persists for life, indicating that H. pylori is 
well adapted to the gastric environment.
Prevalence of H. pylori infection varies among coun-
tries and within different racial groups within the same 
country. The highest rates of infection are generally asso-
ciated with low socio‐economic status, crowding, poor 
sanitation and unclean water supplies [5].
In the developed countries the prevalence of H. pylori 
is lower than 40  % but in some developing countries 
more than 50  % of children are infected by the age of 
10 years with prevalence of infection rising to more than 
80 % in young adults [6]. In Ivory Coast, 55 % of children 
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aged <10 years have been reported to be infected, while 
in northern Nigeria and Gambia, 50  % of children 
under 5 years are infected [7]. A recent study in Soweto 
found 46  % of children at 1  year and 100  % of children 
at 12 years to be infected with H. pylori [7]. The preva-
lence of H. pylori in dyspeptic patients has been reported 
to be 75 % in Ghana [3, 4], 91.3 % in Ivory Coast [8] and 
72–91 % in Nigeria [9, 10].
The diagnosis of H. pylori infection relies on the various 
testing methods which may be invasive or non-invasive. 
There are invasive techniques such as histological exami-
nation, bacterial cultures, rapid urease test, use of deoxy-
ribonucleic acid probes, and polymerase chain reaction 
(PCR) analysis all of which require an endoscopy and a 
biopsy. Non-invasive techniques such as urea breath tests, 
immunoglobulin G and M serology, Stool antigen test, gas-
tric juice PCR, and urinary excretion of N15 ammonia do 
not require endoscopy. These various methods have been 
found to be sensitive and specific [1] but require skilled 
persons to perform them correctly. H. pylori urease test is 
fast, simple and does not need highly experienced labora-
tory staff to accurately identify H. pylori infection in the 
endoscopy unit within few hours of the procedure [11].
Epigastric pain, dyspepsia, haematemesis and mel-
aena have been the commonest reasons for endoscopy. 
Chronic duodenal ulcer, acute gastritis, duodenitis and 
oesophagitis were the commonest diagnoses in Korle Bu 
Teaching Hospital from January 1995 to December 2002 
[3]. H. pylori plays an important role in the aetiopatho-
genesis of peptic ulcer disease among Ghanaians [3, 4]. 
Previous studies in Korle Bu Teaching Hospital using 
urease test confirmed positive results in 75 % of all biopsy 
specimen [3]. Early diagnosis and treatment can lead to 
the eradication of H. pylori which will reduce H. pylori 
related peptic ulcer disease. H. pylori testing schemes 
in Accra are diverse and non-systematic. Upper gastro-
intestinal (GI) endoscopy is an established method of 
investigation in Korle Bu Teaching Hospital for H. pylori 
diagnosis using antral biopsies for histology. However, it 
is not routinely performed. The current practice in Korle 
Bu Teaching Hospital involves making a diagnosis based 
on endoscopic findings. Occasionally biopsies may be 
taken for histologic conformation of H. pylori infection.
This study determined the current incidence of H. pylori 
infection in Korle Bu Teaching Hospital and assessed the 
feasibility of an endoscopic based H. pylori diagnosis and 
its accuracy using a Helicobacter urease test (HUT) as a 
gold standard in a cross-sectional study of patients.
Methods
The study was conducted at the Endoscopy Unit of 
Korle Bu Teaching Hospital. It is a referral hospital with 
over 1800 beds for in-patients and has several specialist 
clinics, wards, pharmacies and reference laboratories. 
The study protocol was approved by Ethical and Protocol 
Review Committee of the School of Medicine and Den-
tistry, University of Ghana and all participating patients 
or their relatives provided written informed consent.
Seventy-six patients between 16 and 81 years referred 
for upper gastrointestinal endoscopy with dyspeptic 
symptoms were recruited for this study. Baseline bio-data 
were obtained from all patients and diagnosis of gastric 
disorders were made based on the presence of atrophic 
mucosa, oedematous mucosa, red spots or streaks and 
erosions suggesting inflammation and active or healing 
ulcers. Endoscopic diagnosis was made at the discretion 
of the endoscopist. Gastric antral mucosal biopsies of 
adequate size were then taken for H. pylori urease test-
ing (HelicotecUT® Plus, Emergo Europe). In regions 
of atrophic gastritis, the biopsies were taken more 
proximally.
Helicobacter urease test (HelicotecUT® Plus)
Biopsy samples, approximately 2–3 mm each were taken 
from the antralgastric mucosa and placed on the yellow 
colored well containing urea and a pH indicator. The pro-
duction of the urease enzyme by H. pylori results in the 
decomposition of urea into bicarbonate and ammonia 
which causes the pH to rise and the colour of the dot to 
change from yellow to red or pink. Positive results were 
read within 5 to 30 min. Samples that were weakly posi-
tive took up to 1 h to develop and no colour change at 1 h 
was regarded negative.
Statistical analysis
All data were entered into Statistical Package for Social 
Science (ver.17.0; SPSS, Chicago, IL) and imported into 
Stata™ version 10 (StataCorp, College Station, Texas, 
United States) for statistical analyses. Data were summa-
rized as frequencies and proportions.
Results
A total of 76 patients were recruited for the study of 
which 43 (56.6  %) were females and 33 (43.4  %) were 
males. The median age of the study participants was 
45.0 years [IQR 30.5–63.5]. A vast majority of the study 
subjects (88.2  %, n =  67) were from urban areas and 9 
(11.8 %) were from rural areas. Severity of symptoms was 
assessed to be mild in 9 (12.0 %) and moderate to severe 
in 66 (88  %) of the patients. Endoscopic diagnosis was 
positive for H. pylori in 51 patients (67.1 %). However, the 
overall prevalence of H. pylori using the HUT among the 
recruited patients was 51.3 % [95 % CI 40.0–63.0].
Table 1 shows the distribution of the various symptoms 
reported by the patients. A total of 39 patients recruited 
in the study were positive for H. pylori urease test. The 
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most reported symptom by patients was epigastric pain 
(67.1  %, n  =  51). Among these patients reporting with 
epigastric pain, 74.4  % (n  =  29) tested positive for H. 
pylori urease test. For patients reporting with dyspepsia 
23.1 % (n = 9) were positive for HUT (Table 1).
Table  2 shows the various endoscopy findings. The 
most frequent endoscopy finding was gastritis (59.2  %, 
n = 45). Seventeen patients (22.4 %) had normal endos-
copy results. A total of 26 (66.7  %) of the patients who 
tested positive to HUT were diagnosed with gastri-
tis whilst 8 (20.5  %) were diagnosed with gastric ulcer 
(Table 2).
Table  3 shows the association between the various 
exposure characteristics and HUT. In the univariate anal-
ysis, age grouping, dwelling status, endoscopy findings 
and endoscopy H. pylori diagnosis were not associated 
with HUT (p  >  0.05). In the multivariate analysis, gen-
der and symptom severity were associated with H. pylori 
urease test results. The odds of a female showing positive 
test results for HUT was 2.73 times compared with males 
(OR 2.73 [95  % CI 1.02–7.33], p  =  0.0460) although 
this association is marginal (Table  3). Symptom sever-
ity was associated with HUT results such that the odds 
of a patient reporting with moderate to severe symptoms 
having a positive HUT test results was 12.06 times (OR 
12.06 [95 % CI 1.38–105.59], p = 0.024) compared with 
patients who reported with mild symptoms (Table 3).
Table 4 shows the various medications that the patients 
were taking and how it related to the H. pylori status as 
detected by HUT and by endoscopic diagnosis. 18  % of 
patients who admitted to taking PPI’s were HUT positive 
while 51 % were negative.
Diagnostic yield of endoscopic diagnosis is 55.3  %. 
Using endoscopic diagnosis as the index test and HUT 
as the reference standard, the sensitivity and specific-
ity of the index test were 71.8 % [95 % CI 55.1–85.0] and 
37.8 % [95 % CI 22.5–55.2] respectively. Further analysis 
indicated that the area under the receiver operated char-
acteristics curve was 0.55 [95  % CI 0.44–0.65] indicat-
ing that the endoscopic diagnosis test do not predict H. 
Table 1 Frequency of symptoms of patients attending endoscopy clinic at the Korle Bu Teaching Hospital in Accra, Ghana
a   %s may not add up to 100 as one patient be diagnosed with more than one endoscopic finding
Symptom H. pylori urease test results Endoscopic diagnosis results
Positive N = 39 n,  %a Negative N = 37 n,  %a Positive N = 51 n,  %a Negative N = 25 n,  %a
Epigastric pain 29 (74.4) 22 (59.5) 35 (68.6) 16 (64.0)
Nausea 3 (7.7) 0 (0) 2 (3.9) 1 (4.0)
Vomiting 1 (2.6) 0 (0) 1 (2.0) 0 (0)
Dyspepsia 9 (23.1) 5 (13.5) 7 (13.7) 7 (28.0)
Chest pain 7 (17.9) 6 (16.2) 9 (17.6) 4 (16.0)
Hematemesis 4 (10.3) 8 (21.6) 8 (15.7) 4 (16.0)
Malena 3 (7.7) 9 (24.3) 8 (15.7) 4 (16.0)
Regurgitation 1 (2.6) 4 (10.8) 3 (5.9) 2 (8.0)
Table 2 Frequency of  endoscopy findings of  patients attending endoscopy clinic at  the Korle Bu Teaching Hospital 
in Accra, Ghana
a   %s may not add up to 100 as one patient be diagnosed with more than one endoscopic finding
Endoscopic finding H. pylori urease test results Endoscopic diagnosis results
Positive N = 39  
n,  %a
Negative N = 37  
n,  %a




Gastritis 26 (66.7) 19 (51.4) 40 (78.4) 5 (20.0)
Gastric ulcer 2 (5.1) 4 (10.8) 6 (11.7) 0 (0)
Duodenal ulcer 6 (15.4) 4 (10.8) 10 (19.6) 0 (0)
Gastric polyp 0 (0) 1 (2.7) 0 (0) 1 (4.0)
Normal 6 (15.4) 11 (29.7) 2 (3.9) 15 (60.0)
Candidiasis 0 (0) 1 (2.7) 1 (2.0) 0 (0)
Reflux esophagitis 1 (2.6) 0 (0) 1 (2.0) 0 (0)
Oesophageal stricture 0 (0) 1 (2.7) 1 (2.0) 0 (0)
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pylori status (as determined by HUT) better than chance. 
After excluding those on PPI, diagnostic yield was 58 %, 
sensitivity of 75.03 [95  % CI 56.6–88.5] and specific-
ity of 38.8  % [95  % CI 13.9–68.4]. The area under the 
receiver operated characteristics curve was 0.51 [95 % CI 
0.37–0.66] implying that in patients who have not been 
exposed to PPI endoscopic diagnosis test do not predict 
H. pylori status.
Discussion
The most common symptoms leading to referral for 
upper GI endoscopy were epigastric pain, dyspepsia, 
upper gastrointestinal bleeding (haematemesis and mel-
aena) and chest pain respectively which is the same as 
that reported in earlier publications [3]. The current 
study found the incidence of H pylori infection in Korle 
Bu Teaching Hospital to be 51.3  % based on the HUT. 
The prevalence is much lower than that quoted in other 
studies from West Africa [3, 4, 9] which have shown a 
high prevalence of H. pylori. Previous studies in Korle Bu 
Teaching Hospital reported an incidence of 75  % [3, 4]. 
However, a recent publication also reports an H. pylori 
prevalence of 69.7  % (1999) and 45.2  % (2012) in Accra 
[12]. This suggests a change in H. pylori prevalence with 
time.
Gastritis (59.2  %) was the most common identifiable 
lesion at endoscopy in this study. One study done in Tan-
zania with H. pylori prevalence of 65  % also reported 
gastritis as the most common finding and gastritis and 
duodenal ulcer were statistically associated with H. 
Table 3 Factors associated with positive H. pylori urease test
Characteristic H. pylori urease test Crude OR [95 % CI] p value Adjusted OR  
[95 % CI]
p value
Positive n,  % Negative n,  %
Gender
 Female 26 (66.7) 17 (46.0) 2.35 [0.93–5.95] 0.069 2.73 [1.02–7.33] 0.046
 Male 13 (33.3) 20 (54.1) Ref Ref
Age group
 <20 1 (2.6) 1 (2.7) 1.33 [0.07–24.32] 0.846 – –
 20–29 9 (23.1) 8 (21.6) 1.50 [0.41–5.43] 0.537 – –
 30–39 9 (23.1) 5 (13.5) 2.40 [0.60–9.67] 0.218 – –
 40–49 4 (10.3) 7 (18.9) 0.76 [0.17–3.42] 0.723 – –
 50–59 7 (18.0) 4 (10.8) 2.33 [0.52–10.48] 0.269 – –
 ≥60 9 (23.1) 12 (32.4) Ref
Dwelling
 Rural 4 (10.3) 5 (13.9) 0.71 [0.13–3.63] 0.629 – –
 Urban 35 (89.7) 31 (86.1) Ref
Symptom severity
 Moderate/severe 38 (96.4) 28 (77.8) 10.86 [1.29–94.05] 0.009 12.06 [1.38–105.59] 0.024
 Mild 1 (2.6) 8 (22.2) Ref Ref
Endoscopy finding
 Abnormal 28 (73.7) 28 (77.8) 0.80 [0.24–2.64] 0.682 – –
 Normal 10 (26.3) 8 (22.2) Ref
Endoscopic diagnosis
 Positive 28 (71.8) 23 (62.2) 1.55 [0.59–4.06] 0.373 – –
 Negative 11 (28.2) 14 (37.8) Ref
Table 4 Comparison of  medications with  H. pylori urease 
test and with the endoscopic diagnosis










 Yes 7 (18.0) 19 (51.4) 14 (27.5) 12 (48.0)
 No 32 (82.0) 18 (48.6) 37 (72.5) 13 (52.0)
Antacid
 Yes 9 (23.1) 8 (21.6) 14 (27.5) 3 (12.0)
 No 30 (76.9) 29 (78.4) 37 (72.5) 22 (88.0)
H2 blocker
 Yes 1 (2.6) 0 (0) 1 (2.0) 0 (0)
 No 38 (97.4) 37 (100) 50 (98.0) 25 (100)
NSAID
 Yes 13 (33.3) 8 (21.6) 17 (33.3) 4 (16.0)
 No 26 (66.7) 29 (78.4) 34 (66.7) 21 (84.0)
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pylori. 72  % of gastritis and 89.5  % of duodenal ulcers 
were H. pylori positive [13]. Based on previous preva-
lence studies, it has been established that the finding of 
a non-bleeding duodenal ulcer has a positive predictive 
value of over 90  % for H. pylori diagnosis, making con-
firmatory tests not mandatory. However, the positive pre-
dictive values for gastric ulcers, bleeding duodenal ulcers 
and perforated duodenal ulcers are lower and confirma-
tory tests would be necessary [14].
Nearly 58  % of gastritis and 60  % of duodenal ulcers 
tested positive for H. pylori, while 33 % of gastric ulcers 
were also positive. Interestingly our study did not find 
any positive association between duodenal ulcers, gas-
tric ulcers or gastritis and a positive HUT. This may be 
explained by the fact that, among the 10 patients with 
duodenal ulcer, 3 of the 4 patients who were HUT neg-
ative admitted to using PPI’s. While of the 6 patients 
diagnosed with gastric ulcer, 3 of the 4 who had nega-
tive HUT admitted to using PPI’s. Cohen et al. [14] have 
reported that the use of PPI’s may lead to unreliable H 
pylori diagnosis.
Moderate to severe symptoms were associated with 
HUT results such that the odds of a patient reporting 
with moderate to severe symptoms of having a posi-
tive HUT test result was 12.06 times (OR 12.06 [95 % CI 
1.38–105.59], p  =  0.024) compared with patients who 
reported with mild symptoms. This means endoscopy 
with H. pylori diagnosis and treatment is mandatory in 
these patients whereas those with mild symptoms may be 
managed without H. pylori testing.
The gold standard recommended by the World Gas-
troenterology Organisation Global Guidelines, 2010 is 
endoscopy and rapid urease test which may not be read-
ily available or cost effective in developing countries. 
They recommend then that in resource limited settings 
with a high prevalence, the decision to treat may be based 
on the assumption that H. pylori is present. This has been 
the practice over the years, however, recent development 
has seen the introduction of several endoscopy set ups in 
both public and private facilities. This has brought with 
it increased opportunities for the accurate diagnosis and 
treatment of H. pylori. Accurate diagnosis and treatment 
is necessary if the prevalence is not as high as previously 
reported. The empirical treatment with antibiotics based 
on endoscopic diagnosis and assumption of high preva-
lence should be discouraged. Efforts should be made to 
make an accurate diagnosis of H. pylori before treatment. 
Where the HUT is not available other tests should be 
done such as histological diagnosis or stool for H. pylori 
antigen. The lower prevalence we report may be due to 
improving standards of living and sanitation in Ghana as 
compared to previous studies published several years ago 
also using HUT [3, 4]. In addition the vast majority of our 
study subjects were from urban areas where the standard 
of living is higher. However, the frequent use of antibiot-
ics may also contribute to the relatively low prevalence 
being reported recently [12]. Also the recent use of PPI’s 
may contribute to the low prevalence. Of all the patients 
who admitted to taking PPI’s only 18 % had positive HUT 
as compared to 51 % who tested negative. While for those 
who denied PPI use, 82  % had positive HUT and 49  % 
were negative. This supports the fact that recent use of 
PPI’s may result in falsely negative HUT results [14].
With regards to the endoscopic diagnosis this study 
reports a diagnostic yield of 55.3 % with a sensitivity and 
specificity of 71.8 % [95 % CI 55.1–85.0] and 37.8 % [95 % 
CI 22.5–55.2] respectively, indicating that the endoscopic 
diagnosis does not predict H. pylori status (as determined 
by HUT) better than chance. After excluding those on 
PPI, analysis resulted in a diagnostic yield of 58 %, sen-
sitivity of 75.03 [95  % CI 56.6–88.5] and specificity of 
38.8 % [95 % CI 13.9–68.4]. The value of endoscopic diag-
nosis of H. pylori is unclear. The value of the HUT in the 
patients who have recently been on PPIs and antibiotics 
maybe limited. In this case treatment based on the endo-
scopic diagnosis should be considered as recommended 
by WHO. On the other hand in treatment naive patients, 
the HUT maybe more reliable and treatment can be pre-
scribed when indicated.
It is known that certain endoscopic mucosal features 
indicate H. pylori infection such as atrophic changes, 
rugal hyperplasia, oedema, spotty erythema, linear ery-
thema and haemorrhage, amongst others. However, rec-
ognition and diagnosis depends on the experience of the 
endoscopist. Several studies including that by Khaloo 
et al. (41.8 %) [15] and Redeen et al. (43–53 %) [16] have 
reported a low diagnostic yield. Khazuhiro et al. however, 
published a relatively higher diagnostic yield in the H. 
pylori-uninfected (88.9 %) but lower in H. pylori-infected 
(62.1 %) and in the H. pylori-eradicated (55.8 %) patients 
[17]. This current study, like others, does not support 
endoscopic diagnosis of H. pylori as a standard of care.
Magnifying endoscopy affords the opportunity to make 
an accurate endoscopic diagnosis of H. pylori based on 
the surface structure of the gastric mucosa and has sensi-
tivity and specificity of 100 and 92.7 % respectively for H. 
pylori infected mucosa [18]. This facility is not available 
at many endoscopy centers worldwide and not in Ghana 
and other developing countries. It may now be cost effec-
tive to make an accurate diagnosis before treatment so as 
to cut down cost on antibiotics, its side effects and reduce 
antibiotic resistance.
The obvious advantage of the rapid urease test in our 
environment is that it is inexpensive (less than $10/
test), does not require any technical expertise and gives 
rapid results within an hour. It is also reliable with the 
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sensitivity of Campylobacter-like organism (CLO) test 
75–98 % and specificity 95–100 % [14]. This will improve 
the accurate diagnosis especially where endoscopic 
expertise is not certain.
With histologic diagnosis the disadvantages are sampling 
errors, observer variations, high cost and long duration of 
processing. There is also an additional delay in our facility 
as the patient is responsible for getting the specimen to the 
pathologist and getting the report back to the physician.
Limitation
One of the limitations of our study is taking antral biopsy 
samples. We also did not have the sufficient resources 
to recruit more patients, which may have improved 
the statistical power of our studies. This study was also 
undertaken in a single medical center, Korle Bu Teaching 
Hospital, which may not be a general representation of 
Ghana although the patients came from variety of ethnic 
groups and socioeconomic backgrounds.
Conclusion
The incidence of H. pylori infection in Ghana may be lower 
than previously reported due to changing socioeconomic 
factors, increased PPI and antibiotic use. To determine 
the true incidence of H. pylori infection in Ghana a larger 
study cutting across all the socio-economic classes needs to 
be done on a treatment naive population. The endoscopic 
diagnosis alone of H. pylori infection is not sufficient as 
it has a low sensitivity and specificity and depends on the 
experience of the endoscopist. The rapid HUT is simple 
and inexpensive and should be introduced routinely at all 
endoscopy centers in Ghana and other developing coun-
tries. Endoscopists at these centers should be educated on 
its interpretation based on patient’s drug history.
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